| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/14/1995 | US5389642 Exhibit antagonistic properties toward angiotensin(II); useful for treatment of hypertensioni, aldosteronism, cardiac insufficiency, increased intraocular pressure and disorders of the central nervous system |
| 02/09/1995 | WO1995004045A1 Compounds as pde iv and tnf inhibitors |
| 02/08/1995 | EP0637238A1 Treatment of macular degeneration |
| 02/08/1995 | EP0637203A1 Regulation of the immune system |
| 02/07/1995 | US5387608 Ocular hypotensive agents for treatment of glaucoma; smooth muscle relaxants |
| 02/07/1995 | US5387594 Administering for topical and systemic treatment of |
| 02/07/1995 | US5387589 Administering rapamycin |
| 02/07/1995 | US5387394 Grapefruit seed extract including essential oils as preservatives |
| 02/02/1995 | WO1995003036A1 Anti-angiogenic compositions and methods of use |
| 02/02/1995 | CA2472404A1 Combination of stent and anti-angiogenic factor |
| 02/02/1995 | CA2468375A1 Anti-angiogenic compositions, uses and methods |
| 02/01/1995 | EP0636127A1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 02/01/1995 | EP0636125A1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 02/01/1995 | EP0636022A1 Chemical prevention or reversal of cataract by phase separation inhibitors |
| 02/01/1995 | EP0549594B1 (2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using same |
| 01/31/1995 | US5385945 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds |
| 01/31/1995 | US5385939 Preventing the axial elongation myopia in the eye by administering a gama-aminobutyric acid receptor antagonist |
| 01/31/1995 | US5385927 Hydroxy-3-[1-(1H-imidazol-4-yl)alkyl]-benzenecarboximidamides and their use in treating glaucoma |
| 01/31/1995 | US5385898 Hypertensive agents; cardiovascular disorders; renin inhibitors; glaucoma |
| 01/31/1995 | US5385734 Horseradish preparation for the treatment of nasal and sinus dysfunction |
| 01/31/1995 | CA1334168C Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers |
| 01/26/1995 | WO1995002600A1 Antiallergic imidazoazepines |
| 01/26/1995 | WO1994028014A3 Peptide inhibitors of urokinase receptor activity |
| 01/25/1995 | EP0634932A1 Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists |
| 01/25/1995 | EP0634916A1 Method and means for preventing secondary cataract |
| 01/25/1995 | CN1097735A Derivative of fatty acid and pharmaceutical composition containg same |
| 01/25/1995 | CN1027504C Imidazolyl-alkenoic acids |
| 01/24/1995 | US5384408 Nervous system disorders such as Alzheimer*s and senility |
| 01/24/1995 | CA2038409C Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase |
| 01/17/1995 | US5382596 Substituted 2-aminotetralins |
| 01/11/1995 | EP0633261A1 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 01/11/1995 | EP0633259A1 Sulfonylaminopyrimidines, their preparation and their use as medicine |
| 01/11/1995 | EP0633025A1 Pharmaceutical composition containing 3-methyl-1-phenyl-2-pyrazolin-5-one for the treatment of ophthalmological diseases |
| 01/11/1995 | EP0632726A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |
| 01/10/1995 | US5380711 Methods for delipidation of skin and cerumen removal |
| 01/08/1995 | CA2127519A1 Pharmaceutical composition useful for treating ophthalmological diseases |
| 01/05/1995 | WO1995000517A1 Process for producing imidazole derivative |
| 01/05/1995 | WO1995000482A1 Piperidine derivatives and process for their production |
| 01/05/1995 | WO1995000176A1 Compositions for treating hypoxia-associated ocular complications |
| 01/05/1995 | WO1995000136A1 Method for treating hyperkeratosis and diseases mediated by proteases |
| 01/05/1995 | WO1994022445A3 Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine |
| 01/05/1995 | CA2164955A1 Method for treating hyperkeratosis and diseases mediated by proteases |
| 01/04/1995 | CN1096960A Smelling medicine and the bag and container for the medicine |
| 01/03/1995 | US5378723 Cholinergic agonist and blocking agents |
| 01/03/1995 | US5378475 Sustained release drug delivery devices |
| 12/28/1994 | EP0630244A1 Muscarinic agonists |
| 12/28/1994 | EP0630240A1 Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists |
| 12/28/1994 | EP0630232A1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor |
| 12/28/1994 | CN1096783A Salt of derivative of 4-pyrimidone and preparation and medical application of same |
| 12/27/1994 | US5376668 Cholinergic agents as cognition activators in treatment of Alzheimer*s disease |
| 12/27/1994 | US5375693 Methods and compositions for treating allergic disorders and other disorders metabolic derivatives of terfenadine |
| 12/27/1994 | US5375611 Chemical modification of the posterior surface of the lens capsule for preventing cell attachment and growth |
| 12/27/1994 | CA1333714C Quinoline ether alkanoic acids for use as inhibitors of leukotriene biosynthesis |
| 12/22/1994 | WO1994029309A1 Spiro-substituted azacycles as neurokinin antagonists |
| 12/22/1994 | WO1994029297A1 2-oxo-1,2,3,4-tetrahydroquinoline derivatives |
| 12/22/1994 | WO1994029262A1 Lipoxin compounds |
| 12/22/1994 | WO1994028913A1 Methods and pharmaceutical compositions useful for treating neurological disorders |
| 12/22/1994 | WO1994028900A1 Methods and compositions for lowering intraocular pressure |
| 12/22/1994 | WO1994028870A1 Preparations containing silicon dioxide to improve the taste thereof |
| 12/22/1994 | CA2164733A1 Methods and compositions for lowering intraocular pressure |
| 12/22/1994 | CA2163995A1 Spiro-substituted azacycles as neurokinin antagonists |
| 12/22/1994 | CA2160368A1 Preparations containing silicon dioxide to improve the taste thereof |
| 12/21/1994 | CN1027065C Tetralin esters of phenols or benzoic acids |
| 12/14/1994 | EP0628556A1 Imidazopyridines |
| 12/14/1994 | EP0628041A1 Heterocyclic compounds and their preparation and use |
| 12/14/1994 | EP0628032A1 Quinazolinone antianginal agents |
| 12/14/1994 | EP0627933A1 Bystander suppression of autoimmune diseases |
| 12/14/1994 | CN1096197A Compositions containing esters of unsaturated fatty acids |
| 12/13/1994 | US5373017 Renin inhibitor |
| 12/11/1994 | CA2125458A1 Pyrimidine compounds and their use as pharmaceuticals |
| 12/08/1994 | WO1994028145A2 Expression of urokinase plasminogen activator inhibitors |
| 12/08/1994 | WO1994028014A2 Peptide inhibitors of urokinase receptor activity |
| 12/08/1994 | WO1994027979A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 12/08/1994 | WO1994027592A1 Use of dihydroliponic acid as an ophthalmologic agent and for the suppression of incompatability reactions at the interfaces between implants and living body tissue |
| 12/08/1994 | WO1994027576A1 Nasal drug delivery composition containing nicotine |
| 12/08/1994 | CA2163741A1 Peptide inhibitors of urokinase receptor activity |
| 12/08/1994 | CA2163089A1 Nasal drug delivery composition containing nicotine |
| 12/08/1994 | CA2162855A1 Expression of urokinase plasminogen activator inhibitors |
| 12/08/1994 | CA2162467A1 Use of dihydroliponic acid as an ophthalmologic agent and for the suppression of incompatability reactions at the interfaces between implants and living body tissue |
| 12/08/1994 | CA2125077A1 Imidazopyridine |
| 12/07/1994 | EP0627407A1 (7S)-7-(2(3-chlorophenyl)-2-hydroethylamino-5,6,7,8-tetrahydro-naphthalen-2-yloxy acetic acid, their pharmaceutically acceptable salts with a beta-3-adrenergic agonist activity and pharmaceutical compositions containing them |
| 12/07/1994 | EP0626955A1 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
| 12/06/1994 | USRE34805 Benzonaphthalene derivatives and their use in therapeutic and cosmetic compositions |
| 12/06/1994 | US5371108 Tear film over ocular surface comprising layer of gel of oil and wax |
| 12/01/1994 | DE4345199A1 Use of dihydrolipoic acid |
| 11/30/1994 | EP0626372A1 2-hydroxy-3- 1-(1H-imidazol-4-yl)alkyl benzenecarboximid-amides for the treatment of glaucoma |
| 11/30/1994 | EP0626367A1 (7S)-7-(1R)-2-(3-chlorophenyl)-2-hydroethylamino-5,6,7,8-tetrahydronaphtalen-2-yloxy acetic acid, their pharmaceutically acceptable salts with a beta-3-adrenergic agonist activity and pharmaceutical compositions containing them |
| 11/30/1994 | EP0626193A1 Positively charged polyvinylidene fluoride membrane |
| 11/30/1994 | EP0625904A1 Bimodal molecular weight hyaluronate formulations and methods for using same |
| 11/30/1994 | EP0625903A1 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
| 11/30/1994 | EP0366765B1 Antiglaucoma compositions containing combinations of sympathomimetic agents and beta-1 selective beta-blockers |
| 11/29/1994 | US5369127 Treatment of glaucoma |
| 11/29/1994 | US5369117 5-(3-formylamino-4-hydroxyphenyl)-3-(1-(4-methoxyphenyl)prop-2-yl)-oxazolidines |
| 11/29/1994 | US5368865 Suspendible composition and process for preparing the same |
| 11/28/1994 | CA2124289A1 2-hydroxy-3-¬1-(1h-imidazol-4-yl)alkyl|-benzenecarboximidamides |
| 11/24/1994 | WO1994026735A1 Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
| 11/24/1994 | WO1994026269A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton |
| 11/24/1994 | WO1994026268A1 Methods and compositions using optically pure (+)-zileuton |
| 11/24/1994 | WO1994026249A1 Compositions and methods for reparation and prevention of fibrotic lesions |
| 11/24/1994 | CA2161978A1 Methods and compositions for treating asthma, atherosclerosis and inflammatory diseases using optically pure (-)-zileuton |